Seeking Alpha

Teva Pharma (TEVA): Q4 EPS of $1.32 misses by $0.01. Revenue of $5.2B misses by $0.06B. (PR)

Teva Pharma (TEVA): Q4 EPS of $1.32 misses by $0.01. Revenue of $5.2B misses by $0.06B. (PR)
From other sites
Comments (1)
  • doc47
    , contributor
    Comments (1358) | Send Message
     
    To all the "buy Teva, it's dirt cheap..." crowd that appears here regularly: IT JUST GOT CHEAPER!!!!
    7 Feb 2013, 09:48 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs